Company intelligence / Profile preview

Givaudan

Ownership: Public · GIVN
Employees: ~15852
Development stage: Other

Overview

Givaudan develops and supplies flavours, fragrances, active cosmetic ingredients and wellbeing solutions for the food & beverage and beauty industries. It leverages biotechnology for sustainable ingredient production but does not conduct clinical trials or have therapeutic products.

Industry: Non-Drug Biotech

Partnerships

Collaborates with major food & beverage brands and beauty companies globallyPartners with startups via co-development accelerators/incubators

Financials

Market cap: $131.6B
Total revenue: $28.8B
Enterprise value: $132B

Beyond the preview

Go deeper on Givaudan.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Givaudan.

Explore the full profile